CTOs on the Move

PetVivo

www.petvivo.com

 
PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo`s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.petvivo.com
  • 5251 Edina Industrial Boulevard
    Minneapolis, MN USA 55439
  • Phone: 952.405.6216

Executives

Name Title Contact Details
David Masters
Director of Science and Technology Profile

Similar Companies

Valeritas

Valeritas is committed to developing and commercializing innovative treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes. Valeritas` portfolio is headlined by the V-Go® disposable insulin delivery device, which is being commercialized and reimbursed in a specialty pharmaceutical model and is distributed through retail pharmacy.

D-Sharp Dental

D-Sharp Dental Inc. is a Burlington, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanomix

Our Vision is to make healthcare accessible to patients, without compromise, by delivering the highest quality, fastest, cost effective and portable detection systems that bring the patient and caregiver closer together.

XRI Inc

XRI Inc is a Warwick, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Euclid Systems Corporation

Build Your Proactive Myopia Management Practice With Euclid Orthokeratology!Euclid Systems Corporation is a global leader in Advanced Orthokeratology and Proactive Myopia Management. Proven on millions of eyes around the world, Euclid Ortho-K lenses are designed for the individual patient`s eyes. Thanks to the power of Three Factor Fitting, integrating Euclid orthokeratology into your practice is easy! Simply provide three parameters: RX, K Readings, and HVID. This efficient, empirical process yields a category-leading 87%* first fit success. No trial lenses required. With headquarters in, Virginia, USA, Euclid manufactures all products exclusively in the United States with approval from the U.S. Food & Drug Administration (FDA). The company additionally has offices in Shanghai and Beijing, China, and is leading global efforts in myopia management in children.